Mutation test for diagnosing myeloproliferative disorders like polycythemia vera.
The V617F mutation is seen in a number of myeloproliferative disorders such as polycythaemia vera, essential thrombocytosis and idiopathic myelofibrosis.
Quantitative JAK2 V617F
To aid in the differential diagnosis and prognostic risk classification for myeloproliferative neoplasms, e.g. polycythaemia vera, essential thrombocythaemia and primary myelofibrosis
JAK2
PCR genotyping
2 weeks
73325 – criteria apply
If not MBS eligible please contact 1800 822 999 for details
Standard pathology request form
Blood 10mL EDTA tube or Bone Marrow 4mL EDTA tube
Blood or bone marrow
None
